Eli Lilly’s Experimental Alzheimer’s Drug Failed in Large Trial

The drug maker said the drug, solanezumab, had not helped patients with mild symptoms of the disease, a result that may affect prospects for similar tests underway.
By PAM BELLUCK from NYT Health http://ift.tt/2ggYmuh
via IFTTT
Clinical Trials, Drugs (Pharmaceuticals)
Source The New York Times
Làm đẹp Blog 247